Zomedica CEO receives grant of 1M stock options

The options vest in stages, beginning on the grant’s first anniversary and continuing monthly until November 6, 2030.

Available on EDGAR 11/09/2026 - 05:07 PM EST Accepted by SEC EDGAR 11/09/2026 - 05:07 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Zomedica Corp. CEO Larry C. Heaton II received a grant of 1,000,000 options to buy common stock on November 6, 2026, with an exercise price of $0.10 per share and an expiration date of November 5, 2036. One quarter of the options vest on the first anniversary of the grant, followed by 1/48 vesting monthly until fully vested on November 6, 2030.

Insider Trade Summary

Grant/Award: 1,000,000 shares

Grant/Award 1 txn

Insider HEATON LARRY C II

Role CEO

Type	Security	Shares	Price	Value
Grant/Award	Options to buy Common Stock F1	1,000,000	$0.00	$0.00

Holdings After Transaction: Options to buy Common Stock — 1,000,000 options (Direct)

Holdings Before and After: Options to buy Common Stock, 0 to 1,000,000 options (Direct)

Footnotes (1)

1. F1. one quarter (1/4) of the options to vest on the first anniversary of the date of grant and 1/48 to vest monthly thereafter until fully vested on 11/6/2030

Key Figures

Options granted: 1,000,000 options Exercise price: $0.10 per share Vesting schedule: One quarter at the first anniversary; 1/48 monthly thereafter +1 more

4 metrics

Options granted 1,000,000 options Grant dated November 6, 2026

Exercise price $0.10 per share Options to buy common stock

Vesting schedule One quarter at the first anniversary; 1/48 monthly thereafter Fully vested on November 6, 2030

Expiration date November 5, 2036 Options granted November 6, 2026

Key Terms

vesting, options to buy Common Stock, exercise price

3 terms

vesting financial

"one quarter (1/4) of the options to vest"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

options to buy Common Stock financial

"Options to buy Common Stock"

exercise price financial

"options to buy Common Stock at $0.10 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many options did ZOMDF CEO Larry C. Heaton II receive?

Zomedica Corp. CEO Larry C. Heaton II received a grant of 1,000,000 options to buy common stock on November 6, 2026. The options have an exercise price of $0.10 per share and expire November 5, 2036.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HEATON LARRY C II

(Last) (First) (Middle)

1101 TECHNOLOGY DRIVE

STE 100

(Street)

ANN ARBOR MICHIGAN 48108

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Zomedica Corp. [ ZOMDF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options to buy Common Stock	$0.1	11/06/2026		A		1,000,000		(1)	11/05/2036	Common Stock	1,000,000	$0.00	1,000,000	D

Explanation of Responses:

1. one quarter (1/4) of the options to vest on the first anniversary of the date of grant and 1/48 to vest monthly thereafter until fully vested on 11/6/2030

	/s/Larry Heaton	11/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)